Solgar Ubiquinol 100mg Coenzyme Q10 Dietary Supplement in Active Form for Maximum Absorption Necessary for Energy Production at the Cellular Level with Antioxidant Properties 50 Softgels

Solgar’s Ubiquinol provides 100mg of the world’s most scientifically researched CoQ-10 ingredient, Kaneka Ubiquinol.

Ubiquinol 100 mg is the active form of coenzyme CoQ-10. CoQ-10 coenzyme exists in two chemical forms – oxidized (ubiquinone) and reduced (ubiquinol). Ubiquinol is found in large amounts in body tissues that are very metabolically active such as skeletal muscle, heart muscle and liver cells.

In younger, healthy adults, the conversion of ubiquinone (the most common form of CoQ-10) to ubiquinol in the body’s cells is almost immediate. However, as we age CoQ-10 levels decline and the conversion of CoQ-10 (ubiquinone) to ubiquinol is less efficient.

It provides a strong antioxidant effect, protecting cells from oxidative stress caused by harmful free radicals. Also, it contributes to normal blood pressure and generally reduces heart complications.

Finally, it exhibits an excellent synergistic effect with anti-hyperlipidemia drugs. It appears from studies that it reverses the appearance of side effects in the muscular system caused by this particular medication.

The product is designed for ease of use with the environmentally conscious consumer in mind, providing high quality Ubiquinol in sustainably sourced soft fish gelatin.

Useful for people with an active lifestyle, people over 40 or those who want general well-being.

Use Instructions

To be taken preferably with a meal.
Assimilation time: Less than 30 minutes.

Dosage

Adults: 1 capsule daily.

Contraindications-Interactions

It should not be taken by pregnant or lactating women.

Consult your doctor if you are under medication or have health problems.

Precautions

Do not exceed the recommended daily dose.

To be kept in a place out of the sight and reach of small children.

To be stored in a dry and cool place, away from sunlight.

Nr Prot. Notification EOF: 50007/08.07.2011. The Notification Number does not take the place of a marketing authorization from the EOF. This product is not subject to a licensing process.